当前位置：首页 > 文献互助 > 互助详情

Efficacy and Safety of BI 1358894 in Patients With Borderline Personality Disorder复制

定风波 1小时前 6 10 求助中 帖子自动结束时间: 2026-02-09 09:38:58

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.4088/jcp.24m15523复制

文献链接: https://www.psychiatrist.com/jcp/efficacy-safety-bi-1358894-borderline-personality-disorder-phase-2-trial/复制

其他信息:

出版社: Physicians Postgraduate Press, Inc
作者: Jennifer B. Dwyer; Christian Schmahl; Manabu Makinodan; Sarah K. Fineberg; Stephanie Sommer; Jan Wruck; Ante Jelaska; Abidemi Adeniji; Marianne Goodman

上一篇：Efficacy, Tolerability, and Safety of TRPC4/5 Inhibitor BI 1358894 in Patients With Major Depressive Disorder and Inadequate Response to Antidepressants

下一篇：Toward More Trustworthy QSAR: A Systematic Discussion on Data Set Partitioning

互助时间线

2026-02-04 09:38:58 [发起求助]

最新发布的求助

DAPK2 Regulates PKM2 Phosphorylation at Threonine 45 to Facilitate Disturbed Flow-Induced Atherosclerosis 1分钟前
Comparing clinical effect sizes of Souvenaid TM , lecanemab, and donanemab in early Alzheimer’s disease 3分钟前
Deep contrastive learning enables genome-wide virtual screening 8分钟前
Osteoinduction mechanism of calcium phosphate biomaterials in vivo: a review 14分钟前
Bayesian Data Analysis 42分钟前
Palladium-Catalyzed Annulation of Aryl Heterocycles with Strained Alkenes 57分钟前
In vivo systemic evaluation of nasal drug absorption from powder formulations in rats 1小时前
Reflections on Alnylam 1小时前
Toward More Trustworthy QSAR: A Systematic Discussion on Data Set Partitioning 1小时前
Efficacy and Safety of BI 1358894 in Patients With Borderline Personality Disorder 1小时前
Efficacy, Tolerability, and Safety of TRPC4/5 Inhibitor BI 1358894 in Patients With Major Depressive Disorder and Inadequate Response to Antidepressants 1小时前
Update on Alport syndrome: the report of the 2024 International Workshop on Alport syndrome 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com